Denali Therapeutics Inc (DNLI)
$18.94 -1.97% Close Oct 30, 2026 Live
Denali Therapeutics stock today
Denali Therapeutics closed at $18.94 on October 30, 2026, down 1.97% on the day. Over the past year it returned +15.6% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $3.01 billion.
$15.00$20.00$25.00
NovJan 2026MarMayJulSep
| Period | DNLI | S&P 500 (SPY) |
|---|---|---|
| 1 month | -8.4% | -0.9% |
| 3 months | -22.2% | +2.1% |
| Year to date | +14.7% | +11.7% |
| 1 year | +15.6% | +12.4% |
| 3 years | +2.9% | +88.5% |
| 5 years | -60.8% | +76.0% |
Key statistics
- Market value
- $3.01B
- Price / sales
- 834.1
- 52-week range
- $14.41 to $27.21
- Next report
- Nov 3, 2026
About Denali Therapeutics
Biopharmaceutical company developing treatments for neurodegenerative diseases.
Sector: Health Care
More on Denali Therapeutics
- Financials: revenue, earnings and segmentsRevenue +205% in the year to Dec 2023
- Returns: what $1,000 became$1,000 five years ago is $391.73 today
No forecast, no recommendation. This page describes Denali Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.